Optimal Treatment of Miscarriage

Region Skane190 enrolled

Overview

The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

190

Conditions

Abortion, Spontaneous

Interventions

misoprostolDRUG

800 micrograms intravaginally ONCE

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * nonviable intrauterine pregnancy with retained gestational sac in the uterus * the embryo if visible 5 to 35 mm without a heart beat * vaginal bleeding * circulatory stable * hemoglobin at least 80 g/L Exclusion Criteria: * contraindications against misoprostol

Locations (1)

Region Skane, Kvinnokliniken, University Hopsital MAS

Malmo, Sweden

Outcomes

Primary Outcomes

complete miscarriage

Time frame: 10 days

Secondary Outcomes

complete miscarriage

Time frame: 17 days, 24 days, 31 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.